Literature DB >> 2522129

Macrophage factors which enhance the mixed leukocyte reaction initiated by dendritic cells.

K Naito1, K Inaba, Y Hirayama, M Inaba-Miyama, T Sudo, S Muramatsu.   

Abstract

Stimulator cells for the allogeneic MLR are dendritic cells but not macrophages (M phi). M phi, however, enhance the MLR initiated by relatively low doses of dendritic cells. The present report demonstrates that the enhancement of the MLR is mediated by two factors produced by M phi. One is IL-1, inasmuch as it has a Mr approximately 15 kDa, and both partially purified IL-1 and rIL-1 also enhance the MLR. The other has been identified as granulocyte-macrophage (GM)-CSF. It had a Mr approximately 25 kDa, and is reproduced by rGM-CSF. Moreover, the MLR-enhancing activity of both the 25-kDa molecule and rGM-CSF have been neutralized by anti-GM-CSF antiserum. Both IL-1 and GM-CSF have autonomous enhancing activity, but they collaborate with each other in enhancing the MLR. Both factors act on DC to augment their stimulatory activity for allogeneic T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2522129

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  IL-6 enhances the generation of cytolytic T lymphocytes in the allogeneic mixed leucocyte reaction.

Authors:  J E Ming; R M Steinman; A Granelli-Piperno
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

2.  Immunosuppressive function of hepatitis B antigens in vitro: role of endoribonuclease V as one potential trans inactivator for cytokines in macrophages and human hepatoma cells.

Authors:  C Jochum; R Voth; S Rossol; K H Meyer zum Büschenfelde; G Hess; H Will; H C Schröder; R Steffen; W E Müller
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

3.  Interstitial lung macrophages interact with dendritic cells to present antigenic peptides derived from particulate antigens to T cells.

Authors:  J L Gong; K M McCarthy; R A Rogers; E E Schneeberger
Journal:  Immunology       Date:  1994-03       Impact factor: 7.397

4.  Enrichment and characterization of dendritic cells from human bronchoalveolar lavages.

Authors:  C E Havenith; J M van Haarst; A J Breedijk; M G Betjes; H C Hoogsteden; R H Beelen; E C Hoefsmit
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

5.  The induction of cell-associated and secreted IL-1 by iscoms, matrix or micelles in murine splenic cells.

Authors:  M Villacres-Eriksson; M Bergström-Mollaoglu; H Kåberg; K Lövgren; B Morein
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

6.  Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class II-negative progenitor in mouse bone marrow.

Authors:  K Inaba; M Inaba; M Deguchi; K Hagi; R Yasumizu; S Ikehara; S Muramatsu; R M Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

7.  Antigen-presenting capacity of macrophages and dendritic cells in the peritoneal cavity of patients treated with peritoneal dialysis.

Authors:  M G Betjes; C W Tuk; D G Struijk; R T Krediet; L Arisz; R H Beelen
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

8.  Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.

Authors:  K Inaba; M Inaba; N Romani; H Aya; M Deguchi; S Ikehara; S Muramatsu; R M Steinman
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

9.  Understanding the dendritic cell lineage through a study of cytokine receptors.

Authors:  E Kämpgen; F Koch; C Heufler; A Eggert; L L Gill; S Gillis; S K Dower; N Romani; G Schuler
Journal:  J Exp Med       Date:  1994-06-01       Impact factor: 14.307

10.  Proliferating dendritic cell progenitors in human blood.

Authors:  N Romani; S Gruner; D Brang; E Kämpgen; A Lenz; B Trockenbacher; G Konwalinka; P O Fritsch; R M Steinman; G Schuler
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.